<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01820429</url>
  </required_header>
  <id_info>
    <org_study_id>INCORPA</org_study_id>
    <nct_id>NCT01820429</nct_id>
  </id_info>
  <brief_title>Residual Platelet Activity Despite Aspirin Utilization in Coronary Heart Disease</brief_title>
  <official_title>Residual Platelet Activity Despite Aspirin Utilization in Patients With Non ST Elevation Acute Coronary Syndromes: Comparison Between the Acute and Chronic Phases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the response to aspirin in the acute phase with the
      late phase of an acute coronary syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to compare, in the same population, the response to aspirin in
      the initial phase (first 48 hours) with the late phase (after 3 months of discharge)of a non
      ST elevation acute coronary syndrome (angina or acute myocardial infarction).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Compare platelet aggregation between the first 48 hours and 3 months after discharge.</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relation between platelet aggregability and the composite endpoint of death, myocardial infarction, unstable angina and need for revascularization or hospitalization at 3 months after discharge.</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relation between the atherosclerotic burden by coronary angiography with the platelet aggregation in the first 48 hours.</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relation between C reactive protein and interleukin -6 with levels of platelet aggregation.</measure>
    <time_frame>first 48 hours and 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relation between platelet aggregation and the presence or absence of selected polymorphisms.</measure>
    <time_frame>first 48 hours and 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelet aggregation in respect to age, gender, glucose at hospital arrival, glycated hemoglobin, statin, PPI, current smokers, ACE inhibitors, type of ACS presentation.</measure>
    <time_frame>first 48 hours and 3 months</time_frame>
    <description>Cut point for age 65 y, for glycemia 125 mg/dL, for glycated hemoglobin 6%</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">70</enrollment>
  <condition>Coronary Heart Disease</condition>
  <condition>Non ST-elevation Acute Coronary Syndromes</condition>
  <arm_group>
    <arm_group_label>First 48 hours</arm_group_label>
    <description>Patients in the first 48 hours of non ST-elevation acute coronary syndromes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 months after discharge</arm_group_label>
    <description>Patients with 3 months after hospital discharge for non ST-elevation acute coronary syndromes.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        70 patients diagnosed with non ST acute coronary syndrome (unstable angina and myocardial
        infarction without ST elevation), with up to 48 hours of evolution from the onset of
        symptoms.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  Confirmed diagnosis of acute coronary syndrome without ST segment elevation, in the
             first 48 hours after the onset of the clinical symptoms

          -  Regular use of aspirin for at least seven days.

        Exclusion Criteria:

          -  Previous use, in the last 7 days, of another antiplatelet agent than aspirin

          -  Use of antivitamin K in the last 3 weeks

          -  Hemoglobin &lt; 10g/dL and / or hematocrit &lt; 30% or &gt; 50%, platelets count &lt; 100.000/mm3
             or &gt; 500.000/mm3, creatinine clearance &lt; 30 mL / minute

          -  Killip class III or IV

          -  Need for vasopressor or inotropic parenteral medication at inclusion in the study

          -  Percutaneous coronary intervention within 30 days or CABG in the last 90 days prior to
             study entry

          -  Current malignancy

          -  Hematologic diseases

          -  Refusal to sign the inform consent form

          -  Unable to attend the second visit (follow-up) for any reason except for death
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose C Nicolau, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto do Coração (Heart Institute) - Clinical Hospitals, University of São Paulo Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto do Coração (Heart Institute) - Clinical Hospitals, University of São Paulo Medical School</name>
      <address>
        <city>São Paulo</city>
        <zip>05403900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.incor.usp.br</url>
  </link>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2012</study_first_submitted>
  <study_first_submitted_qc>March 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2013</study_first_posted>
  <last_update_submitted>March 25, 2013</last_update_submitted>
  <last_update_submitted_qc>March 25, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Platelet aggregation</keyword>
  <keyword>Aspirin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

